Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Out of 175 different outcomes researchers included in the study, they found people who took GLP-1 medications had ... people who were using other types of medications to lower their blood sugar.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...

However, Clinic Secret has emerged as a potential game-changer in weight loss by offering a clinically proven, accessible solution that leverages the power of GLP-1 medications. In this ...

Share on Pinterest Women with diabetes may get the strongest cardiovascular protection from GLP-1 agonists ... of studies has found that newer medications for type 2 diabetes may help reduce ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

Truveta Research and collaborators Dr. Ezekiel Emanuel and Dr. Ty Gluckman explore trends in patients stopping or restarting GLP-1 medications. This graph shows the time to discontinuation and ...

Now, an analysis of studies has found that newer medications for type 2 diabetes may help reduce the ... “While they act through different biochemical pathways, both GLP-1 agonists and SGLT2 ...